Interview: Matias Pino: Chief Financial Officer: POSIBL

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Latest News

Under Delisting Pressure, IM Cannabis Approves Reverse Stock Split

HCN News Team2026-08-19T02:57:05-08:00August 19th, 2026|

TORONTO – IM Cannabis Corp. (IMCC), a medical Cannabis company operating in Israel and Germany, announced that its board has approved a one-for-thirty share consolidation, effective August 27, with September 15 as the outside date. ...

BREAKING: Johnson & Johnson Signs On to Lead Delix’s $85M Series C

HCN News Team2026-08-19T01:39:59-08:00August 19th, 2026|

NEW BRUNSWICK – Johnson & Johnson has agreed to lead a Series C financing for Delix Therapeutics, the biotech developing non-hallucinogenic drugs designed to promote neuroplasticity in patients with serious psychiatric conditions. The round is ...

Analysis: Wall Street Quietly Tests the Water In Cannabis

HCN News Team2026-08-18T16:25:21-08:00August 18th, 2026|

NEW YORK- For years, institutional investors have largely remained outside the publicly traded Cannabis market. Federal illegality, regulatory uncertainty, limited access to major exchanges and disappointing stock performance have kept most major investment firms on ...